Cargando…
Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
The acquisition of temozolomide resistance is a major clinical challenge for glioblastoma treatment. Chemoresistance in glioblastoma is largely attributed to repair of temozolomide-induced DNA lesions by O(6)-methylguanine-DNA methyltransferase (MGMT). However, some MGMT-deficient glioblastomas are...
Autores principales: | Yi, Guo-zhong, Huang, Guanglong, Guo, Manlan, Zhang, Xi’an, Wang, Hai, Deng, Shengze, Li, Yaomin, Xiang, Wei, Chen, Ziyang, Pan, Jun, Li, Zhiyong, Yu, Lei, Lei, Bingxi, Liu, Yawei, Qi, Songtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658867/ https://www.ncbi.nlm.nih.gov/pubmed/31347685 http://dx.doi.org/10.1093/brain/awz202 |
Ejemplares similares
-
Expression of dynein, cytoplasmic 2, heavy chain 1 (DHC2) associated with glioblastoma cell resistance to temozolomide
por: Wang, Hai, et al.
Publicado: (2016) -
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
por: Thomas, Reena P, et al.
Publicado: (2012) -
Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
por: Qu, Shanqiang, et al.
Publicado: (2023) -
Correction: albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
por: Qu, Shanqiang, et al.
Publicado: (2023) -
Acquired temozolomide resistance in MGMT(low) gliomas is associated with regulation of homologous recombination repair by ROCK2
por: Zhang, Xin, et al.
Publicado: (2022)